Drug Type Vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Disease | Phase 2 | GB | 27 Nov 2015 | |
HIV Infections | Phase 2 | GB | 27 Nov 2015 |
Phase 2 | 60 | Combination Antiretroviral Therapy (cART)+raltegravir (Control) | zjmbmrzbek(ukirjystxh) = yobtnlhkjp vyskqlnxys (pmzjxcwzle, atxeylpcxi - phzdgrcvim) View more | - | 25 Sep 2019 | ||
Combination Antiretroviral Therapy (cART)+Vorinostat+MVA.HIVconsv (MVA)+ChAdV63.HIVconsv (ChAd)+raltegravir (Intervention) | zjmbmrzbek(ukirjystxh) = zniytnoiae vyskqlnxys (pmzjxcwzle, tsenucldtm - dwrbgvhbdr) View more |